660 related articles for article (PubMed ID: 23810723)
21. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK
Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune hepatitis.
Strassburg CP
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):667-82. PubMed ID: 20955969
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis.
Wang Q; Selmi C; Zhou X; Qiu D; Li Z; Miao Q; Chen X; Wang J; Krawitt EL; Gershwin ME; Han Y; Ma X
J Autoimmun; 2013 Mar; 41():140-5. PubMed ID: 23187010
[TBL] [Abstract][Full Text] [Related]
24. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
[TBL] [Abstract][Full Text] [Related]
25. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
Li H; Shi X; Shen H; Li X; Wang H; Li H; Xu G; Chen J
Clin Ther; 2012 May; 34(5):1112-20. PubMed ID: 22503105
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy.
Seela S; Sheela H; Boyer JL
Liver Int; 2005 Aug; 25(4):734-9. PubMed ID: 15998423
[TBL] [Abstract][Full Text] [Related]
27. Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome.
Efe C; Ozaslan E; Kav T; Purnak T; Shorbagi A; Ozkayar O; Berlot AH; Sökmensuer C; Muratori P
Autoimmun Rev; 2012 Mar; 11(5):330-4. PubMed ID: 22001521
[TBL] [Abstract][Full Text] [Related]
28. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.
van Gerven NM; Verwer BJ; Witte BI; van Hoek B; Coenraad MJ; van Erpecum KJ; Beuers U; van Buuren HR; de Man RA; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Mulder CJ; van Nieuwkerk KM; Bouma G;
J Hepatol; 2013 Jan; 58(1):141-7. PubMed ID: 22989569
[TBL] [Abstract][Full Text] [Related]
29. Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.
Pape S; Gevers TJG; Belias M; Mustafajev IF; Vrolijk JM; van Hoek B; Bouma G; van Nieuwkerk CMJ; Hartl J; Schramm C; Lohse AW; Taubert R; Jaeckel E; Manns MP; Papp M; Stickel F; Heneghan MA; Drenth JPH
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2068-2075.e2. PubMed ID: 30625402
[TBL] [Abstract][Full Text] [Related]
30. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
[TBL] [Abstract][Full Text] [Related]
31. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials.
Lamers MM; van Oijen MG; Pronk M; Drenth JP
J Hepatol; 2010 Jul; 53(1):191-8. PubMed ID: 20400196
[TBL] [Abstract][Full Text] [Related]
32. Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis.
Heneghan MA; Allan ML; Bornstein JD; Muir AJ; Tendler DA
J Hepatol; 2006 Oct; 45(4):584-91. PubMed ID: 16876902
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
Richardson PD; James PD; Ryder SD
J Hepatol; 2000 Sep; 33(3):371-5. PubMed ID: 11019991
[TBL] [Abstract][Full Text] [Related]
34. Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis.
Nguyen TM; Daubard M; Le Gall C; Larger M; Lachaux A; Boulieu R
Ther Drug Monit; 2010 Aug; 32(4):433-7. PubMed ID: 20479703
[TBL] [Abstract][Full Text] [Related]
35. Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.
Yu ZJ; Zhang LL; Huang TT; Zhu JS; He ZB
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):873-877. PubMed ID: 31150366
[TBL] [Abstract][Full Text] [Related]
36. Budesonide for juvenile autoimmune hepatitis? Not yet.
Mieli-Vergani G; Vergani D
J Pediatr; 2013 Nov; 163(5):1246-8. PubMed ID: 23932214
[No Abstract] [Full Text] [Related]
37. Drug therapy in the management of type 1 autoimmune hepatitis.
Czaja AJ
Drugs; 1999 Jan; 57(1):49-68. PubMed ID: 9951951
[TBL] [Abstract][Full Text] [Related]
38. The effect of budesonide mouthwash on oral chronic graft versus host disease.
Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
[TBL] [Abstract][Full Text] [Related]
39. Use of sirolimus in the treatment of refractory autoimmune hepatitis.
Chatrath H; Allen L; Boyer TD
Am J Med; 2014 Nov; 127(11):1128-1131. PubMed ID: 24979741
[TBL] [Abstract][Full Text] [Related]
40. Standard Treatment in Adults: Which Steroid? Or without Steroids?
Gleeson D
Dig Dis; 2015; 33 Suppl 2():75-82. PubMed ID: 26640942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
